SEC Form 4 · accession 0001209191-19-011851
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · PACB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Michael Phillips
Officer — SVP, Research & Development
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 8:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001299130
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2019 | A | 8,000 | $0.00 | A | 223,156 | D | |
| Common StockF2 | Feb 15, 2019 | A | 13,605 | $0.00 | A | 236,761 | D | |
| Common StockF3,F4 | Feb 19, 2019 | S | 7,231 | $7.166 | D | 229,530 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date.
- F2Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units.
- F3Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards.
- F4This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.